secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001193125-22-270039
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte prices $650.7M underwritten public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Selling 15M shares at $32.00/share and pre-funded warrants for 3.75M shares at $31.999 each.
- Underwriters exercised option to purchase additional 2,812,500 shares; net proceeds expected ~$650.7M.
- Closing expected October 28, 2022, subject to customary closing conditions.
- Underwriting agreement filed as Exhibit 1.1; pre-funded warrant form filed as Exhibit 4.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522270039/0001193125-22-270039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312522270039/d374961d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-270039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer